IQVIA

Advancing Life Sciences with Data

Somerset, New Jersey, United States

IQVIA was formed in 2016 through the acquisition and merger of IMS Health with Quintiles, later rebranded from QuintilesIMS in 2017. It is a global provider of advanced analytics, technology solutions, and clinical research services, employing approximately 93,000 people across 100+ countries and maintaining access to 1.2 billion non-identified patient records.

IQVIA hero image

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out IQVIA on @MedStartr Today IQVIA was formed in 2016 through the acquisition and merger of IMS Health with Quintiles, later rebranded from QuintilesIMS in 2017. It is a global provider of advanced analytics, technology solutions, and clinical research services, employing approximately 93,000 people across 100+ countries and maintaining access to 1.2 billion non-identified patient records. #AllergyRespiratory #CellGeneTherapy #Dermatology #EarlyPhaseClinicalDevelopment #Endocrinology #GIHepatologyInflammatoryBowelDiseaseCeliac #Nephrology #OncologyBreastCancerColorectalCancerLeukemiaAMLLungCancerMelanomaMultipleMyelomaNonHodgkinLymphomaProstateCancer #Diabetes #HealthyVolunteers #HeartDisease #Hypertension #Lupus #MASH #AtopicDermatitisEczema #ObesityOverweight #MentalBehavioralHealth #Asthma #MultipleSclerosis #InfectiousDiseasesAndVaccines #CardiovascularDisease #CentralNervousSystemDisorders #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/GASqhjPVK-o

Get Involved in IQVIA

How We Help

Problem Statement

The problem IQVIA solves is the complexity and inefficiency in bringing new therapies to patients, addressing the need for data-driven insights, advanced technology, and streamlined clinical research within the life sciences industry.

Core Technology

Advanced analytics, AI-driven solutions, IQVIA Connected Intelligence™, cloud-based CRM application software, IQVIA CORE™, big data, generative AI for pharmacovigilance, machine learning

Key Differentiators

Extensive Data Assets (1.2 billion health records), Advanced Analytics and Technology Innovation (AI/ML for drug discovery, clinical trial optimization, personalized digital healthcare marketing), Global Reach and Infrastructure (operations in over 100 countries, 88,000-93,000 employees), Integrated Approach (end-to-end solutions throughout drug lifecycle), Real-World Evidence (RWE) Platforms, Strong Brand Reputation and Diverse Service Offerings, Strategic Partnerships (e.g., NVIDIA), Dedicated Biotech Focus.

Clinical Focus

Pioneering decentralized and patient-centric clinical trials, accelerating patient recruitment, expertise in biomarkers and antibody drug discovery, expediting new therapies for patients, improving data quality in clinical research.

Target Customers

Life sciences companies, pharmaceutical companies, biotech firms, healthcare providers, contract sales organizations.

Product Stage

Mature

Company Info

Business Model: B2B, SaaS, CRO (Contract Research Organization)
Founded: 2017
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.iqvia.com/

Disease Areas

Technologies

Generative AIAdvanced AnalyticsAI-driven SolutionsIQVIA Connected Intelligence™Cloud-Based CRMIQVIA CORE™Big DataPharmacovigilance AutomationMachine Learning

Clinical & IP

🔬

Clinical Validation

Operates as a Contract Research Organization (CRO) for clinical trials Phase I-IV, offering clinical pharmacology, post-approval services, regulatory affairs, and patient recruitment support for life sciences clients globally.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of IQVIA?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.